Jun 21, 2026, 12:58 AM IST AvanceTechnologies - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) May 30, 2026, 12:57 AM IST AvanceTechnologies - Announcement under ...

Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, today announced a significant expansion of its Asia Pacific and China ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An influx of high-net-worth ...

Avance Clinical is a full-service Contract Research Organization (CRO) headquartered in Australia, with extensive operations across New Zealand, Asia, North America, and Europe. As the market leaders ...

This library serves as a comprehensive reference implementation of MessagePack for JavaScript with a focus on accuracy, compatibility, interoperability, and performance. Additionally, this is also a ...

ADELAIDE, Australia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the ...

Avance Technologies has signed a non-binding term sheet to acquire upto 100% equity stake in Pushpak AI, a Hyderabad-based Computer Vision and Edge AI platform. The announcement comes amid rapid ...

This is the official Neo4j driver for JavaScript. Starting with 6.0, the Neo4j Drivers is no longer on a monthly release cadence. Minor version releases will happen when there are sufficient new ...

Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...

(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...